Tsega Surafel, O'Connor Michelle, Poeran Jashvant, Iberti Colin, Cho Hyung J
Department of Medicine, Mount Sinai Hospital, New York, New York, USA.
Icahn School of Medicine at Mount Sinai, New York, New York, USA.
J Hosp Med. 2018 Jan 1;13(1):38-40. doi: 10.12788/jhm.2869. Epub 2017 Oct 18.
As part of the Choosing Wisely® campaign, the Society of Hospital Medicine recommends against performing "repetitive complete blood count chemistry testing in the face of clinical and lab stability." With this recommendation as a framework, we targeted 2 hospitalist-run inpatient medicine units that employed bedside, scripted, interdisciplinary rounds. Our multifaceted intervention included prompting the hospitalist to identify clinically stable patients for next-day discharge and to discontinue labs when appropriate. It was coupled with the education of the clinicians and a regular data review for the hospitalists and unit staff. Among 2877 discharges included in a 1-year period, there was a significantly decreasing trend after the intervention in the percentage of patients getting labs in the 24, 48, and 72 hours before discharge (-1.87%, -1.47%, and -0.74% decrease per month, respectively; P < 0.05). Our structured, multifaceted approach effectively reduced daily lab testing in the 24 to 48 hours prior to discharge.
作为“明智选择”运动的一部分,医院医学协会建议,在临床和实验室检查结果稳定的情况下,不要进行“重复性全血细胞计数化学检测”。以此建议为框架,我们针对了2个由住院医师管理的内科住院病房,这些病房采用床边脚本化跨学科查房。我们的多方面干预措施包括促使住院医师识别临床稳定、可于次日出院的患者,并在适当的时候停止实验室检查。同时还对临床医生进行了教育,并定期为住院医师和病房工作人员进行数据审查。在1年期间纳入的2877例出院病例中,干预后,出院前24小时、48小时和72小时进行实验室检查的患者百分比呈显著下降趋势(每月分别下降1.87%、1.47%和0.74%;P<0.05)。我们结构化的多方面方法有效减少了出院前24至48小时的日常实验室检查。